Published in Medical Letter on the CDC and FDA, September 17th, 2006
Venlafaxine HCl tablets are indicated for the treatment of major depressive disorder. They are the AB-rated generic version of Wyeth's Effexor tablets, which had annual U.S. sales of approximately $154 million for the 12 months ending June 30, 2006.
Mylan Laboratories Inc. is a pharmaceutical company with three principal subsidiaries: Mylan Pharmaceuticals Inc.,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.